Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Choquette, US

Deborah Choquette, Medford, MA US

Patent application numberDescriptionPublished
20080312232Substituted amide derivatives and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.12-18-2008
20090124609Fused heterocyclic derivatives and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.05-14-2009
20090124612Fused heterocyclic derivatives and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.05-14-2009
20090176774Compounds and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.07-09-2009
20090318436Fused heterocyclic derivatives and methods of use - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.12-24-2009
20110118252SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.05-19-2011
20110118285HETEROCYCLES AS PROTEIN KINASE INHIBITORS - Selected fused imidazole or triazole derivatives are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.05-19-2011
20120070413METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.03-22-2012
20120107275FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE - Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.05-03-2012

Patent applications by Deborah Choquette, Medford, MA US

Jack Choquette, Palo Alto, CA US

Patent application numberDescriptionPublished
20110078427TRAP HANDLER ARCHITECTURE FOR A PARALLEL PROCESSING UNIT - A trap handler architecture is incorporated into a parallel processing subsystem such as a GPU. The trap handler architecture minimizes design complexity and verification efforts for concurrently executing threads by imposing a property that all thread groups associated with a streaming multi-processor are either all executing within their respective code segments or are all executing within the trap handler code segment.03-31-2011

Jack Choquette, Mountain View, CA US

Patent application numberDescriptionPublished
20100153689Processor instruction used to determine whether to perform a memory-related trap - Instruction execution includes fetching an instruction that comprises a first set of one or more bits identifying the instruction, and a second set of one or more bits associated with a first address value. It further includes executing the instruction to determine whether to perform a trap, wherein executing the instruction includes selecting from a plurality of tests at least one test for determining whether to perform a trap and carrying out the at least one test. The second set of one or more bits is used in the determination of whether to perform the trap; and the plurality of tests includes a matrix test that determines whether a data value being stored as pointed to by the first address value is escaping from one of a plurality of managed memory types to another one of the plurality of managed memory types and generates a trap in the event that the data value is determined to be escaping from one of the plurality of managed memory types to another one of the plurality of managed memory types, wherein the matrix test is based on a matrix associated with garbage collection and a matrix entry located using at least some of the first set of one or more bits and at least some of the second set of one or more bits.06-17-2010

Jack H. Choquette, Mountain View, CA US

Patent application numberDescriptionPublished
20110041015DETECTING SOFTWARE RACE CONDITIONS - Detecting a race condition is disclosed. An indication of a store operation to a memory address is received. An identifier of the memory address is stored. The identifier is used to detect an occurrence of a memory operation that is not associated with a previous ordering operation.02-17-2011

Jack Hilaire Choquette, Palo Alto, CA US

Patent application numberDescriptionPublished
20120110586THREAD GROUP SCHEDULER FOR COMPUTING ON A PARALLEL THREAD PROCESSOR - A parallel thread processor executes thread groups belonging to multiple cooperative thread arrays (CTAs). At each cycle of the parallel thread processor, an instruction scheduler selects a thread group to be issued for execution during a subsequent cycle. The instruction scheduler selects a thread group to issue for execution by (i) identifying a pool of available thread groups, (ii) identifying a CTA that has the greatest seniority value, and (iii) selecting the thread group that has the greatest credit value from within the CTA with the greatest seniority value.05-03-2012

Kent D. Choquette, Urbana, IL US

Patent application numberDescriptionPublished
20100220758DIRECT MODULATED MODIFIED VERTICAL CAVITY SURFACE EMITTING LASERS - A laser system having separately electrically operable cavities for emitting modulated narrow linewidth light with first, second and third mirror structures separated by a first active region between the first and the second and by a second active region between the second and the third. The second mirror structure has twenty of more periods of mirror pairs.09-02-2010
20110243170DIRECT MODULATED MODIFIED VERTICAL-CAVITY SURFACE-EMITTING LASERS AND METHOD - A laser system having separately electrically operable cavities for emitting modulated narrow linewidth light with first, second and third mirror structures separated by a first active region between the first and the second and by a second active region between the second and the third. The second mirror structure has twenty of more periods of mirror pairs.10-06-2011

Scott A. Choquette, Kansas City, MO US

Patent application numberDescriptionPublished
20110016414SYSTEM IMAGE CUSTOMIZATION TOOL - A system image customization tool provides an efficient and cost effective way to implement a highly customizable system image for a digital device. The system image customization tool controls application installation, device settings, and selection, delivery methods and licensing options for products, applications and services with minimal or no customer interaction from the customer's first out of box experience with the device and through the lifecycle use of the device. The system image customization tool provides retailers, original equipment manufacturers and products, applications and services providers a way to create new distribution channels and partnerships.01-20-2011